Charles Schwab
TELA icon

Charles Schwab’s TELA Bio TELA Stock Holding History

Charles Schwab’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,911
Closed -$243K – 3680
2024
Q1 		$243K Sell
42,911
-3,000
-7% -$19.8K ﹤0.01% 3209
2023
Q4 		$304K Hold
45,911
– – ﹤0.01% 3216
2023
Q3 		$367K Buy
45,911
+3,031
+7% +$28.2K ﹤0.01% 3159
2023
Q2 		$434K Buy
+42,880
New +$439K ﹤0.01% 3119
2021
Q2 		– Sell
-18,547
Closed -$277K – 3536
2021
Q1 		$277K Hold
18,547
– – ﹤0.01% 3266
2020
Q4 		$279K Hold
18,547
– – ﹤0.01% 3188
2020
Q3 		$307K Buy
18,547
+6,861
+59% +$96.4K ﹤0.01% 3022
2020
Q2 		$152K Buy
+11,686
New +$153K ﹤0.01% 3206

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Charles Schwab's TELA Position: Q2 2024 in Review

Charles Schwab sold out of TELA Bio (TELA) in Q2 2024, closing a stake of 42,911 shares — an estimated $243K sold.

Charles Schwab first reported a position in TELA in Q2 2020 and held it in 8 quarters. The position peaked at $434K in Q2 2023. 68 funds tracked by Wall St. Rank hold TELA as of Q2 2024.

  • Charles Schwab reported no remaining TELA Bio position as of Q2 2024 after selling out during the quarter.
  • Charles Schwab sold 42,911 TELA Bio shares in Q2 2024, an estimated $243K.
  • Charles Schwab first reported a position in TELA Bio in Q2 2020 and held it in 8 quarters.
  • Charles Schwab's TELA Bio position peaked at $434K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held TELA Bio as of Q2 2024.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.